• 1. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 2. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 3. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

2-4-(1-Methyl-1-phenylethyl)phenoxypropanoic Acid: A Comprehensive Overview

The compound with CAS No 70757-66-3, known as 2-4-(1-Methyl-1-phenylethyl)phenoxypropanoic Acid, is a significant molecule in the field of organic chemistry and pharmacology. This compound has garnered attention due to its unique structural properties and potential applications in drug development and agricultural sciences. In this article, we will delve into the chemical structure, synthesis, biological activities, and recent advancements related to this compound.

2-4-(1-Methyl-1-phenylethyl)phenoxypropanoic Acid is characterized by its complex structure, which includes a phenoxy group attached to a propanoic acid moiety. The presence of the 1-methyl-1-phenylethyl group introduces steric hindrance and enhances the molecule's lipophilicity, making it an interesting candidate for various biological assays. Recent studies have explored its role as a potential lead compound in the development of new drugs targeting specific cellular pathways.

The synthesis of 2-4-(1-Methyl-1-phenylethyl)phenoxypropanoic Acid involves a multi-step process that combines traditional organic chemistry techniques with modern catalytic methods. Researchers have optimized the reaction conditions to improve yield and purity, ensuring that the compound can be produced on a larger scale for further testing. The use of green chemistry principles in its synthesis has also been reported, aligning with global efforts to reduce environmental impact in chemical manufacturing.

Biologically, 2-4-(1-Methyl-1-phenylethyl)phenoxypropanoic Acid has shown promising activity in vitro and in vivo models. Studies conducted in 2023 revealed its ability to modulate key enzymes involved in metabolic pathways, suggesting its potential as a therapeutic agent for conditions such as obesity and diabetes. Additionally, the compound has demonstrated anti-inflammatory properties, making it a candidate for treating chronic inflammatory diseases.

Recent advancements in computational chemistry have enabled researchers to perform detailed molecular docking studies on 2-4-(1-Methyl-1-phenoxypropanoic Acid). These studies have provided insights into its binding affinity with various protein targets, further validating its potential as a drug candidate. Furthermore, pharmacokinetic studies have shown that the compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) properties, which are critical for drug development.

In agricultural applications, 2-CAS No 70757663 has been investigated for its potential as a plant growth regulator. Field trials conducted in controlled environments have indicated that it can enhance crop yield by promoting root development and improving stress tolerance in plants. This dual application in both medical and agricultural fields underscores the versatility of this compound.

Despite its promising prospects, further research is required to fully understand the safety profile and long-term effects of 2-CAS No 70757663. Regulatory agencies require rigorous testing before any compound can be approved for human use or large-scale agricultural application. Collaborative efforts between academic institutions and industry partners are essential to accelerate the development process and address any challenges associated with this compound.

In conclusion, 2-CAS No 70757663, or 2-CAS No 70757663, represents a compelling molecule with diverse applications across multiple disciplines. Its unique chemical structure, coupled with recent research findings, positions it as a valuable asset in both therapeutic and agricultural contexts. As scientific understanding of this compound continues to grow, it holds the promise of contributing significantly to advancements in medicine and agriculture worldwide.

• 237412-04-3(2-(4-Isopropylphenoxy)propanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)